Abstracts - Poster Presentations

82

Homeop

several methodological flaws, which prevent the general-ization of the results. There are strong scientific evidencesin some clinical indications, which demonstrate measur-able significant clinical effects of homeopathy beyond apossible placebo effect.

Homoeopathy in tuberculosis

Sudhir Batra1,*, Kusum S. Chand2, Raj K.Manchanda3

and Renu Mittal3

1Directorate of ISM &Homoeopathy, Health & FamilyWelfare Department, Govt. of Delhi, India2Department of Homoeopathy, Pushpanjali CrosslayHospital, New Delhi, India3Central Council of Research in Homoeopathy, Govt. ofIndia

*Corresponding author.E-mail: drsbatra2000@gmail.com (S. Batra)

Background: Globally India accounts for one fifth ofnew Tuberculosis(TB) cases. TB kills more adults in Indiathan any other infectious disease. India has gone throughtwo phases of TB control after availability of effectivechemotherapy for TB namely :(1) National TuberculosisProgram (NTP) and (2)Revised National TuberculosisControl Program (RNTCP)TB treatment has seen different eras from only support-

ive treatment through sanatoria, monotherapy, combina-tion therapy, domicillary treatment, long term(conventional treatment), short course treatment, intermit-tent and now finally to a now-a-days popular DirectlyObserved Treatment eShort Course(DOTS).Methods: Tuberculosis (TB) has been known since an-

tiquity. In spite of effective antibiotic treatment,it is still a major worldwide public health problem.

Endogenous factors are important in the development ofactive disease. Homeopathic medicines have the potentialfor immune-modulation and hence to influence endoge-nous factors in disease.In India, patients with tubercular lymphadenitis (TBLN)

often consult homoeopaths but such cases are seldom docu-mented. The objective of the present study is to documentsuch experience.A retrospective exploratory study of 25 positively diag-

nosed cases of TBLN has lead to the development of a ho-moeopathic regime consisting of:� a patient specific constitutional medicine,� one disease specific biotherapy (Tuberculinum) and� Silicea6x as supportive medicine.Homeopathy can be used as a complement to conven-

tional anti tubercular treatment (ATT) with beneficial re-sults. Further validation in controlled trials withimmunological markers is required.Conclusion: Homeopathy can be integrated as an add-

on/ complementary medicine to conventional anti-tuber-cular treatment of Tuberculosis for better compliance andoutcome ratio. Hence, a combined approach (Allopathic

athy

and Homeopathic) could be an answer in the preventionand treatment of Tuberculosis.Keywords: Tubercular lymphadenitis; Endogenous fac-

tors; Retrospective exploratory study; Homoeopathy;Constitutional treatment; Tuberculinum; Silicea

Effectiveness ofhomeoprophylaxis for infectiousdisease prevention

Kate Birch* and Cilla Whatcott

*Corresponding author.E-mail: Internationalkatebhom@hotmail.com (K. Birch)

Background: North America has the highest Autismrate in children of anywhere in the world with the currentdata (2013) revealing 1 in 50 being afflicted. Chronic dis-ease in children, including allergies, asthma, skin condi-tions and various developmental delays are alsoincreasing. Currently the US has the highest vaccinationrate of any country with legal pressures mounting torescind available vaccine exemptions. There is no viablealternative to ever-increasing recommendations for vac-cines that are filled with toxic chemicals and administeredin methods deleterious to immature immune systems. Thedevelopment of a safe, green and effective method of dis-ease prevention will support the healthy education ofgrowing immune systems and improve long-term healthoutcomes of children. Homeopathic nosodes targetingeight different diseases are administered to infants andchildren by parents and caregivers over a span of 44monthsand overseen by trained healthcare practitioners. Data iscollected at regular intervals to assess health parameterswhile tracking the ongoing health status of subjects overa period of five years. Ongoing educational and supportprograms are in place to facilitate effective implementationand oversight of this low cost, easily adaptable program.Results: This is ongoing research with data collected

from between 2009 and 2013 from approximately 300 chil-dren at various stages in the program. Results of effective-ness and efficacy regarding disease incidence will becompared to that of children who have undergone currentstate vaccine schedules. General health outcomes reflecting5 different parameters, including frequency and intensityof symptoms, as compared to vaccinated children, willinclude: ear, nose, throat pathology; asthma; allergies;skin conditions; and behavioral/neurological pathology.Effectiveness will be determined by patient/parent compli-ance (parent compliance to administering to their children)and long-term health outcomes compared to data on thehealth status of vaccinated children as collected by inde-pendent agencies. Based upon preliminary studies by IsaacGolden, ND, PhD the potential to implement a method ofdisease prevention that is effective, safe, improves long-term health outcomes, and operates outside of the current

Abstracts - Poster Presentations

83

economic model of vaccine programs has far-reaching ef-fects for both global health and economic sustainability.Keywords: Autism, Developmental delays, Infectious

disease, Vaccination, Homeopathic nosodes, Long-termhealth outcomes

A critical examination of evidenceregarding the use ofindividualised homeopathy in thetreatment of bipolar spectrumdisorders

Kimberlee Blyden-Taylor

E-mail: KBlyden-Taylor@ccnm.edu (K. Blyden-Taylor)

Introduction: Diagnosis of bipolar spectrum disorders(BSD) has substantially expanded in scope due to changingdiagnostic criteria. As a result, the societal impact of thesedisorders has garnered greater public awareness andconcern. The aim of this paper is to identify evidence in re-gards to individualised homeopathic treatment of patientswith symptoms of BSD.Method: A literature review was undertaken to deter-

mine published evidence of the effect of individualised ho-meopathic treatment for bipolar spectrum disorders.Results: Ten relevant articles were identified. Claims for

the effect of homeopathy for BSD exclusively includedocumentation of single cases presented as informal abbre-viated interviews or as summaries. Strengths of single casereports include detailed descriptions of patients’ symptompictures and length of follow-up periods. Weaknessesinclude the varied quality of published case reports, lackof diagnostic criteria, lack of triangulation for content vali-dation, and a lack of standardization making cross casecomparison unreliable. Case reports are typically retro-spective and generally do not include rival explanationsfor positive changes. To date, no clinical trials have beenpublished.Conclusion: Documentation of the successful effect of

individualised homeopathy in treatment of bipolar spectrumcannot reliably be said to exist at this time. Informal singlecase reports are a historical backbone of knowledge transferin the homeopathic community and have provided greatdepth of insight into practitioners’ methodology as well aspatient experience. However, lack of consistency in the styleand quality of case reporting and in the rigour of analysislimits cross-case comparison and generalizability.Thompson’s (2004) innovative Formal Case Study (FCS)

approach offers a viable alternative to the standard casereport. FCS is grounded in established practices of qualita-tive research; it utilizes grounded propositions which aretested by a variety of analytic tools, focusing on identifica-tion of deviant cases and rival explanations of outcomes.Although it requires more work on the part of the homeo-path-author, the FCS offers the potential for building a clin-ically useful database of cases amenable to cross-case

comparison and generalizability. Whole Systems Research(WSR) offers further research potential into the synergisticeffects inherent in complex treatment systems.

Treatment of chemotherapyrelated fatigue: an opportunity touse the n-of-1 trial design inindividualized homeopathy

David Brul�e1,* and Dugald Seely2

1Riverdale Homeopathic Clinic, Toronto, Canada2Ottawa Integrative Cancer Centre, Ottawa, Canada

*Corresponding author.E-mail: david@rhronline.ca (D. Brul�e)

Background: Cancer-related fatigue has been describedas a subjective feeling of physical, emotional, and/orcognitive tiredness. Fatigue has a multidimensionalcomponent with correlations to other symptoms such aspain, insomnia, anorexia, nausea, vomiting, anxiety anddepression. Homeopathic treatments show some potentialin relieving cancer-related fatigue, are easy to deliver anddemonstrate strong compliance.The n-of-1 trial design is a scientifically rigourousmethod

of studying particular clinical conditions. The method in-volves the administration of either verum or placebo accord-ing to a binary randomization allocation sequence unknownto both the clinician and participant. During the subsequenttreatment period the participant will be given the other allo-cation (verum or placebo). The following pairs of alloca-tions will also be randomized with treatment continuingfor as long as the participant is in the trial.Using the n-of-1 design to test the efficacy of homeopa-

thy is challenging primarily due to the unpredictability ofthe length of time of the effects of homeopathic treatment.On the plus side, the individualization of homeopathictreatment can be harnessed by repeated testing in a singleparticipant. This may be especially fruitful in an individualwho is sensitive to or who seems to respond actively to ho-meopathic substances.Methods/Design: An n-of-1 pilot trial of individualized

homeopathic treatment of fatigue in a single adult who isundergoing any type of chemotherapy administered inter-mittently (i.e. not continuously) will be performed. Theparticipant will have a homeopathic consultation within 3days of a round of chemotherapy (“treatment period”)and will be administered either verum or placebo accordingto the n-of-1 design. The pairs of allocations will continuefor as long as the participant is undergoing chemotherapytreatment. Each round of chemotherapy will provide aconsistent washout thus reversing any of the prior effectsof the homeopathic remedy. The washout and reversibilityin this particular clinical context (in which a highly toxicchemotherapy and antidote is given) will provide one ofthe key requirements for effective application of the n-of-1 design.

Homeopathy